Increased levels of lipoipolysaccaride (LPS) and lipotoxic lipid products lead to activation of Kupffer cells, which release chemotactic factors (e.g. CCL2), and proinflammatory cytokines, and generate oxidative stress-related products including reactive oxygen species (ROS). These factors contribute to hepatocyte injury, which in turn, through danger signals, cause further activation of toll-like receptors (TLRs). In addition, inflammation and damage contribute to hepatic stellate cell activation and fibrosis.